Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-047745

President and CEO sold 27,796 shares at an average $35.75 ($993,652)

  • President and CEO acquired 27,796 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mack David Henry President and CEO 2021-07-20 Option exercise +1,029 $0.53 $545 13,499 D: show line 1 in the form
Mack David Henry President and CEO 2021-07-20 Sale −1,029 $35.53 $36,560 12,470 D: show line 2 in the form
Mack David Henry President and CEO 2021-07-21 Option exercise +26,767 $0.53 $14,187 39,237 D: show line 3 in the form
Mack David Henry President and CEO 2021-07-21 Sale −26,767 $35.76 $957,092 12,470 D: show line 4 in the form
Open-market sales · 27,796 sh · avg $35.75 · $993,652

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mack David Henry President and CEO 2021-07-20 Option exercise · Stock Option (right to buy) −1,029 473,841 D: show line 5 in the form
Mack David Henry President and CEO 2021-07-21 Option exercise · Stock Option (right to buy) −26,767 447,074 D: show line 6 in the form
Loading xslF345X03/doc4.xml…